Business context and reporting period
Target Corporation’s unaudited Form 10-Q covers the third quarter and first nine months of fiscal 2022, with the quarter ended October 29, 2022. The filing compares the quarter with the period ended October 30, 2021. Although the request metadata says “2021 Q3,” the filing itself is for Q3 2022.
Target operates as a single U.S.-focused retail segment, serving customers through stores and digital channels. Results are subject to seasonal variation.
Financial performance and position
| Metric | Q3 2022 | Q3 2021 | First nine months 2022 | First nine months 2021 |
|---|---|---|---|---|
| Total revenue | $26.5 billion | $25.7 billion | $77.7 billion | $75.0 billion |
| Operating income | $1.0 billion | $2.0 billion | $2.7 billion | $6.9 billion |
| Net earnings | $712 million | $1.5 billion | $1.9 billion | $5.4 billion |
| Diluted EPS | $1.54 | $3.04 | $4.09 | $10.87 |
| Operating income margin | 3.9% | 7.8% | 3.5% | 9.1% |
| Gross margin rate | 24.7% | 28.0% | 23.9% | 29.5% |
- Quarterly revenue rose 3.4%, while operating income fell 49.2%, net earnings fell 52.1%, and diluted EPS fell 49.3%. Nine-month diluted EPS declined 62.4%. Adjusted diluted EPS, a non-GAAP measure, was $1.54 for the quarter and $4.12 for the nine months.
- Comparable sales increased 2.7% in the quarter, reflecting 1.4% traffic growth and a 1.3% increase in average transaction amount. Store-originated comparable sales rose 3.2%; digitally originated comparable sales rose 0.3%.
- Quarterly SG&A was $5.2 billion; its rate increased to 19.7% from 18.9%. Net interest expense was $125 million, versus $105 million.
- Operating cash flow for the first nine months was $552 million, down from $5.6 billion. Capital expenditures were $4.3 billion, compared with $2.5 billion; cash and cash equivalents ended at $954 million, versus $5.8 billion a year earlier.
- Inventory was $17.1 billion at quarter-end, up from $15.0 billion a year earlier. Total current assets were $20.4 billion and current liabilities were $23.8 billion.
- Current and long-term debt and other borrowings totaled $16.4 billion, including $2.1 billion of commercial paper. In September, Target issued $1.0 billion of 4.5% unsecured debt due in 2032. It reported no borrowings under its revolving credit facilities.
Material changes, outlook, and risks
- Management attributed the sharp margin and earnings decline chiefly to higher clearance and promotional markdowns, inventory shrink, merchandise and freight costs, and distribution and inventory-management costs. Retail price increases partly offset these pressures.
- Management described softer discretionary-category trends, which worsened in October; comparable sales growth was supported by beauty and household essentials and food and beverage. The filing reports monthly comparable-sales growth of 2.8% in August, 4.0% in September, and 0.9% in October.
- Earlier-than-expected merchandise arrivals and elevated inventory increased carrying and management costs. Target said supply-chain pressures had improved but noted continued volatility and changing consumer trends.
- Target stated that operating cash flow fell because of lower earnings, higher inventory, and lower accounts-payable leverage. Capital spending increased, principally reflecting store remodels, supply-chain investment, and inflation.
- Target paid $1.3 billion in dividends and returned $2.6 billion through share repurchases in the first nine months; no shares were repurchased in the third quarter. The company declared a quarterly dividend of $1.08 per share, up 20% year over year.
- Management said liquidity from operating cash flow, credit facilities, and capital-market access should be adequate for obligations, planned investment, debt maturities, dividends, and share repurchases for the foreseeable future. This is forward-looking and subject to risks, including market access, operating performance, and credit ratings.
- The filing provides no specific earnings or sales guidance. Target reported no material changes to previously disclosed risk factors or market-risk exposures. It recognized $55 million of impairment charges in the first nine months, versus $84 million in the prior-year period. Prior-year nine-month results included a $335 million pretax gain on the Dermstore sale.
Important facts for investors to verify
- Whether inventory levels and discretionary-category demand improve, and whether markdowns and shrink continue to pressure gross margin.
- Whether operating cash flow recovers as inventory and accounts-payable trends change; also assess planned capital expenditures against cash generation.
- Debt and liquidity: the $2.1 billion commercial-paper balance, refinancing needs, credit-facility availability, and sensitivity to borrowing costs or rating changes.
- How much of the reported earnings comparison reflects operating conditions versus prior-year items, including the Dermstore gain; review the company’s non-GAAP EPS reconciliation.
- The filing’s date and period: this is a Q3 2022 report, not a Q3 2021 report.